The ductus arteriosus is a small blood vessel that connects the pulmonary artery to the aorta in a developing fetus, routing blood away from the lungs. Since a fetus gets all its oxygen from the placenta rather than by breathing, the lungs don’t need much blood flow. The ductus arteriosus acts as a bypass, sending most of that blood straight to the aorta so it can reach the rest of the body. After birth, it closes on its own and is no longer needed.
How It Works During Fetal Development
A fetus has three built-in shortcuts in its circulatory system, all designed to reroute blood around organs that aren’t fully functional yet. Two of these shortcuts bypass the lungs, and the ductus arteriosus is one of them. It sits between the pulmonary artery (the vessel that would normally carry blood to the lungs) and the descending aorta (the body’s main highway for oxygen-rich blood). Specifically, it connects near the point where the left pulmonary artery branches off, joining the aorta just past where a major artery to the left arm exits.
In the womb, only a small trickle of blood actually reaches the fetal lungs. The bulk of it flows through the ductus arteriosus into the aorta and then circulates down to the placenta, where the mother’s blood supply provides fresh oxygen and nutrients. This arrangement is efficient: why pump blood through lungs that aren’t breathing?
What Makes It Close After Birth
The moment a baby takes its first breath, conditions inside the body shift dramatically, and the ductus arteriosus begins to shut down. Two changes drive this process. First, oxygen levels in the blood rise sharply once the lungs start working. Second, levels of a hormone-like substance called prostaglandin E2, which had been keeping the vessel relaxed and open throughout pregnancy, drop quickly.
The rising oxygen triggers a chain reaction in the muscle cells lining the ductus. Oxygen increases the production of reactive molecules inside those cells’ energy-producing structures, which in turn blocks certain channels that normally keep the muscle relaxed. The result is that calcium floods into the muscle cells, causing them to contract and squeeze the vessel shut. In most full-term babies, this functional closure happens within the first 24 to 72 hours of life.
Over the following weeks, the tissue remodels permanently. The once-active blood vessel becomes a tough, fibrous cord called the ligamentum arteriosum. This remnant stays in the chest for life but serves no active purpose. It’s simply a structural leftover from fetal circulation.
When It Stays Open: Patent Ductus Arteriosus
Sometimes the ductus arteriosus doesn’t close. This condition, called patent ductus arteriosus (PDA), is the most common cardiovascular problem in premature infants. The earlier a baby is born, the higher the risk: more than half of infants born before 26 weeks of gestation still have an open ductus after two months. In full-term babies, PDA is much rarer, occurring in roughly 1 in 2,000 births and accounting for 5% to 10% of all congenital heart disease.
A small PDA may cause no symptoms at all. Some people don’t discover they have one until adulthood. Interestingly, studies using cardiac imaging suggest that “silent” PDAs, ones too small to produce any clinical signs, may be present in as many as 1 in 20 births.
A large PDA is a different story. Because the aorta has higher pressure than the pulmonary artery after birth, blood flows backward through the open ductus into the lungs. This floods the lungs with excess blood and forces the heart to work harder. In infants, this can show up as poor feeding, slow weight gain, fast breathing, and breathlessness during eating or crying. Left untreated over time, the increased pressure can damage the small blood vessels in the lungs, a serious and potentially irreversible condition called Eisenmenger syndrome. A large PDA also raises the risk of heart failure and heart infections (endocarditis), where bacteria attach to damaged areas inside the heart.
How a PDA Is Treated
For premature infants diagnosed in the first couple of weeks, medications that block prostaglandin production can often prompt the ductus to close on its own. These drugs work by removing the chemical signal that had been keeping the vessel open. They tend to be most effective when given within the first 10 to 14 days of life.
If medication doesn’t work, or if the baby has health conditions that make those drugs unsafe, there are procedural options. The most common approach after the first year of life is a catheter-based closure, where a small device is threaded through a blood vessel and used to plug the opening. This has largely replaced open surgery as the standard treatment for older infants, children, and adults. Surgical closure through the chest wall is still used when catheter techniques aren’t suitable, particularly in very small or very young infants.
When Doctors Keep It Open on Purpose
In certain congenital heart defects, the ductus arteriosus is actually lifesaving. Some babies are born with heart structures so abnormal that blood can’t reach the lungs or the body through normal pathways. In these “ductal-dependent” heart conditions, the only thing keeping the baby alive is blood flowing through the ductus arteriosus. Doctors administer a synthetic form of prostaglandin E1 intravenously to prevent the ductus from closing, buying time until corrective surgery can be performed. It’s one of the more striking examples in medicine of a structure that’s normally supposed to disappear becoming the most critical vessel in a newborn’s body.